Investor Presentation Fortis Healthcare Ltd - 532843 - Announcement under Regulation 30 (LODR)-Investor Presentation BSE India The investor presentation is attached.
Investor Presentation Fortis Healthcare Ltd - 532843 - Announcement under Regulation 30 (LODR)-Investor Presentation BSE India Relevant Disclosure is attached.
Investor Presentation FORTIS HEALTHCARE LTD. - 532843 - Announcement under Regulation 30 (LODR)-Investor Presentation BSE India Relevant Disclosure is attached.
Investor Presentation FORTIS HEALTHCARE LTD. - 532843 - Announcement under Regulation 30 (LODR)-Investor Presentation BSE India The relevant file is attached
Investor Presentation FORTIS HEALTHCARE LTD. - 532843 - Announcement under Regulation 30 (LODR)-Investor Presentation BSE India The detailed disclosure relating to Investor Presentation is attached.
Investor Presentation FORTIS HEALTHCARE LTD. - 532843 - Announcement under Regulation 30 (LODR)-Investor Presentation BSE India Please find attached investor presentation
Investor Presentation FORTIS HEALTHCARE LTD. - 532843 - Announcement under Regulation 30 (LODR)-Investor Presentation BSE India Please find the enclosed herewith press release and earning presentations for the quarter and year ended March 31, 2024.
Investor Presentation FORTIS HEALTHCARE LTD. - 532843 - Announcement under Regulation 30 (LODR)-Investor Presentation BSE India Pursuant to Regulation 30 of SEBI LODR Regulations, 2015, please find the enclosed press release and earnings presentation for the quarter and period ended December 31, 2023.
Investor Presentation FORTIS HEALTHCARE LTD. - 532843 - Announcement under Regulation 30 (LODR)-Investor Presentation BSE India Pursuant to Reg 30 of SEBI LODR, please find enclosed press release and earnings presentation for the quarter and period ended September 30, 2023.
Investor Presentation FORTIS HEALTHCARE LTD. - 532843 - Announcement under Regulation 30 (LODR)-Investor Presentation BSE India Pursuant to Reg. 30 of SEBI LODR, please find enclosed herewith the Press Release and Earnings Presentation for the Quarter ended June 30, 2023